New precision medicine venture gives Syngenis added firepower

The Sydney Morning Herald - Sep 23, 2026

Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.

Read full article

More News

The Morning Herald

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

NEWSLETTER